INVA Q1 2019 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$55M+5.4% YoY

Gross Profit

$55M100.0% margin

Operating Income

$52M94.5% margin

Net Income

$34M61.2% margin

EPS (Diluted)

$0.31

QoQ Revenue Growth

-30.9%

Cash Flow

Operating Cash Flow

$77M

Free Cash Flow

$77M

Stock-Based Comp.

$605,000

Balance Sheet

Total Assets

$590M

Total Liabilities

$390M

Stockholders' Equity

$188M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$55M	$52M	+5.4%
Gross Profit	$55M	$52M	+5.4%
Operating Income	$52M	$41M	+28.2%
Net Income	$34M	$30M	+14.2%